Edition:
India

Acceleron Pharma Inc (XLRN.OQ)

XLRN.OQ on NASDAQ Stock Exchange Global Market

37.37USD
22 Jun 2018
Change (% chg)

$0.32 (+0.86%)
Prev Close
$37.05
Open
$37.10
Day's High
$37.51
Day's Low
$36.84
Volume
390,434
Avg. Vol
108,239
52-wk High
$46.51
52-wk Low
$29.39

Chart for

About

Acceleron Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its research focuses on key natural regulators of cellular growth and repair, particularly the Transforming Growth Factor-Beta... (more)

Overall

Beta: 1.66
Market Cap(Mil.): $1,680.20
Shares Outstanding(Mil.): 44.04
Dividend: --
Yield (%): --

Financials

BRIEF-Acceleron Reports Q1 Loss Per Share $0.58

* ACCELERON REPORTS FIRST QUARTER 2018 OPERATING AND FINANCIAL RESULTS

09 May 2018

BRIEF-Acceleron Receives FDA Fast Track Designation For Ace-083 In Facioscapulohumeral Muscular Dystrophy

* ACCELERON RECEIVES FDA FAST TRACK DESIGNATION FOR ACE-083 IN FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY (FSHD) Source text for Eikon: Further company coverage:

01 May 2018

BRIEF-Acceleron Pharma Q4 Loss Per Share $‍0.62​

* ACCELERON REPORTS FOURTH QUARTER AND FULL YEAR 2017 OPERATING AND FINANCIAL RESULTS

28 Feb 2018

BRIEF-Acceleron plans to initiate part 2 of ACE-083 FSHD phase 2 trial during Q2 of 2018

* ACCELERON PHARMA INC - PLANS TO INITIATE PART 2 OF ACE-083 FSHD PHASE 2 TRIAL DURING Q2 OF 2018

08 Jan 2018

BRIEF-BioAg Alliance Announces Updated Research And Development Pipeline

* BIOAG ALLIANCE - ANNOUNCED UPDATED RESEARCH AND DEVELOPMENT PIPELINE

04 Jan 2018

Earnings vs. Estimates